文档介绍：372·oloncancer[J].cancerImmunolImmunother,[25]2OO2,51(2):63.[2O]sahaA,BaralRN,chatterjeesK,—cleotidesenhancethetum0rantigen—specificimmuneresponseofananti—idiotypeantibody—inestrategyinCEAtransgenicmice[J].cancerImmunolImmun0ther,(1):1.[21]sahaA,chatterjeesK,FoonKA,ellspulsedwithanantiidiotypeantibodymimickingcarci—noembryonicantigen(CEA)canreverseimmunologicalt0IerancetoCEAandinduceantitumorimmunityincEAtransgenicmice[J].cancerRes,2oo4,64(14):4995.:22],strongTV,—bryonicantigenandhepatitisBsurfaceantigenincolo—rectalcarcinomapatients[J].clincancerRes,2oo2,8(9):]SinbaldiVallebonaP,RasiG,PierimarchiP,—onapeptideexpressedinhumantumorspreventscolorectalcancerlivermetastasesinsyngeneicrats[J].IntJCancer,2O¨O4,11O(1):]welts,RitterG,,|bodyimmunotherapyinpatientswithadvancedcolorectalcancer[,(4):1347.[26][27][28][29][3O][31]HjelmSA,RagnhammarP,FagerbergJ,etaLClinicaleffectsofmonoclonalantibody17—binedwithranulocyte/macrophage—colony—stimulatingfactorandinterleukir卜2fortreatmentofpatientswithadvancedcolorectalcarcinoma[J].cancerImmunolImmunother1999,48(8):463—,LissoniP,AlderiG,[J].Oncology,1996,53(2):263—268